HYDERABAD | 10 September 2026: Accelerating the digitization of its global drug discovery and healthcare delivery operations, biopharmaceutical firm MSD (known as Merck & Co., Inc. in the US and Canada) has formally inaugurated its massively expanded Technology Centre in Hyderabad. Located in the premium tech corridor of HITEC City, this sprawling 2.5-lakh square foot (250,000 sq. ft.) facility marks a critical scale-up from the hub’s initial 2025 launch. By tightly integrating artificial intelligence, advanced data analytics, and software engineering, the center functions as a sovereign capability engine for MSD’s worldwide Human Health business.

KEY HIGHLIGHTS

  • The Scale-Up: Operating out of a shared workspace since its inception in 2025, the strategic transition to a dedicated 2.5-lakh sq. ft. campus enables MSD to significantly expand its specialized engineering headcount and architectural footprint.
  • Deep-Tech Mandate: The localized engineering squads are strictly tasked with building and maintaining enterprise-grade digital solutions. Their operational focus spans artificial intelligence, cloud architecture, cybersecurity, and hyper-automation, moving the capability center far beyond basic IT maintenance.
  • Global Connectivity: Teams based in the HITEC City hub do not operate in a silo. They are seamlessly integrated into MSD’s worldwide technology network, collaborating cross-border to engineer software platforms that enhance enterprise workflows and patient access globally

Headquartered in Rahway, New Jersey, MSD (Merck & Co., Inc. in the US and Canada) is a global biopharmaceutical firm operating at the frontier of medical research and drug discovery. With a legacy spanning over a century, the enterprise develops critical medicines and vaccines for the world’s most challenging diseases, driving major breakthroughs in oncology, infectious diseases, and cardio-metabolic disorders.

Driven by a massive global R&D budget, MSD is actively pivoting toward becoming a “science-led, technology-enabled” organization. By embedding advanced digital infrastructure into its core operations, the corporation aims to accelerate clinical trials, optimize complex biomanufacturing, and fundamentally improve health outcomes on a global scale.

OPERATIONAL BLUEPRINT: THE HYDERABAD TECH CENTER

To navigate the complex regulatory and technical demands of the global pharmaceutical industry, MSD’s expanded facility is structurally designed to support high-end algorithmic workflows:

  • Applied AI & Data Analytics: Software engineers and data scientists at the center build predictive machine learning models and data pipelines. These systems accelerate clinical insights and streamline the massive volumes of telemetry generated by modern biopharma operations.
  • Enterprise Digital Platforms: The capability hub architects secure, scalable enterprise software that unifies MSD’s global supply chain, commercial operations, and internal corporate governance.
  • Cyber-Resilience & Cloud Engineering: As proprietary clinical data becomes an increasingly vulnerable corporate asset, dedicated cybersecurity and cloud computing squads within the facility fortify the enterprise’s digital perimeter against evolving threat vectors.
“

The inauguration of our Hyderabad Tech Centre reflects MSD’s long-term commitment to building world-class digital capabilities that drive our shared purpose…Hyderabad’s vibrant technology ecosystem, deep digital expertise and strong talent pool make it an ideal location for MSD, and we are grateful for the support and engagement of the Telangana government. This Tech Centre strengthens our ability to bring together talent, technology and global collaboration to support scalable solutions that contribute to MSD’s purpose.

– Abhishek Narayan Singh, SVP, Digital Human Health, MSD

Industry Insights

Assessing MSD’s aggressive infrastructural commitment provides critical intelligence into Telangana’s broader macroeconomic trajectory:

  1. The Intersection of Biology and Code: As noted by Minister Sridhar Babu, Hyderabad possesses a rare, structural advantage: it is home to both Genome Valley (a premier life sciences cluster) and one of India’s largest IT corridors. This geographic proximity allows global pharma giants to effortlessly fuse biochemical research with advanced software engineering.
  2. Beyond Generic Manufacturing: The state’s commercial ecosystem hosting over 2,000 life sciences companies is aggressively evolving. Under the localized Next-Gen Life Sciences Policy 2026–30, the region is pivoting away from legacy bulk drug and API manufacturing toward high-value algorithmic R&D, clinical discovery, and global technology creation.
  3. The 100-GCC Milestone: MSD’s expansion directly supports Telangana’s macroeconomic target of operationalizing 100 GCCs (Global Capability Centres) by the end of 2026, building upon the 75 established in the previous year. This momentum is projected to generate approximately 4 lakh (400,000) high-value employment opportunities.
  4. The ‘Bharat Future City’ Initiative: To maintain this deep-tech gravity, the government is developing a massive 2,100-acre life sciences zone and a specialized 100-acre advanced biologics hub, backed by a “1Bio” model offering plug-and-play bio-foundry infrastructure to attract further multinational investment

THE STRATEGIC HORIZON

The formal commissioning of MSD’s massive HITEC City Technology Centre signals a definitive paradigm shift in the global pharmaceutical industry. As the economics of drug discovery become increasingly complex, multinational life sciences corporations can no longer afford to treat software engineering as a secondary support function. Developing next-generation therapeutics and managing secure, international supply chains now requires immense, highly integrated algorithmic bandwidth.

By anchoring its deep-tech capabilities within Hyderabad’s unique bio-digital ecosystem, MSD ensures it commands the sovereign technical agility necessary to drive scalable, AI-powered healthcare solutions. Ultimately, this structural expansion validates an undeniable reality: the sophisticated computational infrastructure required to power the future of global medicine is actively being engineered, optimized, and scaled from within India’s specialized capability hubs

Curated by SSF Global

Tracking the shifts shaping GCCs, enterprise ecosystems, and the future of global business.

Share on      

SSF Global is a Global Community for Enterprise Function Leaders and serves as a research & advisory platform focused on Global Business Services (GBS), Global Capability Centres (GCCs), and the evolution of enterprise innovation in India and beyond. We track, publish, and partner in narratives that shape how capability centres transform into hubs of trust, intelligence, and sustainable growth. We also evaluate, assess and benchmark the GCCs for their performance, maturity and other parameters using our proprietary tools built from the knowledge gained from direct interaction with our members (GCCs & GBS).